166 related articles for article (PubMed ID: 33649717)
1. The Antimicrobial Peptide, Nisin, Synergistically Enhances the Cytotoxic and Apoptotic Effects of Rituximab Treatment on Human Burkitt's Lymphoma Cell Lines.
Mohammadi P; Zangeneh M; Mohammadi-Motlagh HR; Khademi F
Rep Biochem Mol Biol; 2020 Oct; 9(3):250-256. PubMed ID: 33649717
[TBL] [Abstract][Full Text] [Related]
2. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
3. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
4. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
5.
Alsubaie M; Matou-Nasri S; Aljedai A; Alaskar A; Al-Eidi H; Albabtain SA; Aldilaijan KE; Alsayegh M; Alabdulkareem IB
Oncol Lett; 2021 Aug; 22(2):622. PubMed ID: 34267815
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the management of Burkitt's lymphoma.
Levine AM
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385
[TBL] [Abstract][Full Text] [Related]
7. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
8. High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
Weber T; Bötticher B; Mier W; Sauter M; Krämer S; Leotta K; Keller A; Schlegelmilch A; Grosse-Hovest L; Jäger D; Haberkorn U; Arndt MA; Krauss J
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):489-98. PubMed ID: 26341366
[TBL] [Abstract][Full Text] [Related]
9. Combination of
Repetto-Llamazares AHV; Malenge MM; O'Shea A; Eiríksdóttir B; Stokke T; Larsen RH; Dahle J
Eur J Haematol; 2018 Oct; 101(4):522-531. PubMed ID: 29993152
[TBL] [Abstract][Full Text] [Related]
10. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
[TBL] [Abstract][Full Text] [Related]
11. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
Hu T; Gao Y
Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
[TBL] [Abstract][Full Text] [Related]
12. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
[TBL] [Abstract][Full Text] [Related]
13. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Ribrag V; Koscielny S; Bosq J; Leguay T; Casasnovas O; Fornecker LM; Recher C; Ghesquieres H; Morschhauser F; Girault S; Le Gouill S; Ojeda-Uribe M; Mariette C; Cornillon J; Cartron G; Verge V; Chassagne-Clément C; Dombret H; Coiffier B; Lamy T; Tilly H; Salles G
Lancet; 2016 Jun; 387(10036):2402-11. PubMed ID: 27080498
[TBL] [Abstract][Full Text] [Related]
14. Ouabain induces apoptosis and autophagy in Burkitt's lymphoma Raji cells.
Meng L; Wen Y; Zhou M; Li J; Wang T; Xu P; Ouyang J
Biomed Pharmacother; 2016 Dec; 84():1841-1848. PubMed ID: 27894666
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt's lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib.
Jeong Y; Kim SB; Yang CE; Yu MS; Choi WS; Jeon Y; Lim JY
Front Oncol; 2023; 13():1252658. PubMed ID: 37752998
[TBL] [Abstract][Full Text] [Related]
16. Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line.
Deyab M; Elbanani A; Tabal S; Geriani H; Lamami Y; Bredan A; Abulayha A
Cancer Biother Radiopharm; 2014 Mar; 29(2):87-90. PubMed ID: 24256491
[TBL] [Abstract][Full Text] [Related]
17. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
[TBL] [Abstract][Full Text] [Related]
18. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.
Wang N; Zeng GZ; Yin JL; Bian ZX
Biochem Biophys Res Commun; 2019 Nov; 519(3):533-539. PubMed ID: 31537387
[TBL] [Abstract][Full Text] [Related]
19. Biology and treatment of Burkitt's lymphoma.
Yustein JT; Dang CV
Curr Opin Hematol; 2007 Jul; 14(4):375-81. PubMed ID: 17534164
[TBL] [Abstract][Full Text] [Related]
20. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
